Effect of intravenous dexamethasone palmitate compared to dexamethasone on the duration of ropivacaine axillary brachial plexus block
Not Applicable
- Conditions
- Not Applicable
- Registration Number
- KCT0009618
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
* ASA physical status 1-3
* Age: 19-80 years
* Patients with brachial plexus block and scheduled upper extremity surgery under supervised general anesthesia
Exclusion Criteria
* Informed Consent Refusers
* Pregnancy
* Any contraindication to axillary brachial plexus block (Any contraindication to axillary BPB)
* Pre-existing neuropathy involving the surgical limb (Pre-existing neuropathy involving the surgical limb)
* systemic use of corticosteroids for 2 weeks or longer within 6 months of surgery (systemic use of corticosteroids for 2 weeks or longer within 6 months of surgery)
* Allergy to any medication included in the study protocol, including ropivacaine.
Translated with DeepL.com (free version)
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method